医学
基底细胞
阴茎癌
肿瘤科
阴茎
皮肤病科
内科学
外科
作者
Xavier García del Muro,D. Páez López-Bravo,Miler Andrés Cuéllar-Rivas,Pablo Maroto,Patrizia Giannatempo,Daniel Castellano,Miguel Ángel Climent,Begoña P. Valderrama,Alfonso Gómez de Liaño,Laura López-Montero,Leonardo Mina,Daniel Alcalá-López,Miguel Sampayo-Cordero,Andrea Necchi
标识
DOI：10.1016/j.euo.2024.04.021
摘要
Patients with advanced penile squamous cell carcinoma (PSCC) have poor outcomes and very limited therapeutic options are available. Most PSCC cases have high PD-L1 expression, which is associated with worse prognosis. Immunotherapy targeting PD-L1 could benefit patients with PSCC. Our aim was to evaluate the efficacy and safety of the anti-PD-1 antibody retifanlimab in patients with advanced/metastatic PSCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
大力的灵雁
eric888
GingerF
你嵙这个期刊没买
teohsj
Widy
随机发
蓝莓橘子酱
殷勤的紫槐
无极微光
难过的谷芹
iNk
arniu2008
BowieHuang
乐空思
laber
Singularity
YifanWang
风清扬
DotBlot
皖公网安备34019202002308
